KIT D816V‐Negative Smoldering Systemic Mastocytosis in an Adolescent Treated With Midostaurin
Pediatric Blood & Cancer · 03.11.2026
DOI: 10.1002/1545-5017.70809 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 03.11.2026. Verfasst von Güney Küçük Külice und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Allergy and Immunology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pediatric Allergy and Immunology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey.
- Department of Pediatric Hematology and Oncology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey.
- Department of Medical Genetics, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey.
ORCID-Profile: Güney Küçük Külice, Sultan Aydın, Aysel Tekmenuray-Ünal, Ayşe Öz, Enes Onkun, Fatma Betül Özen, Zeycan Canıtez Oral, Fatih Çelmeli
Zitieren
APA
Külice, G. K., Aydın, S., Tekmenuray-Ünal, A., Öz, A., Onkun, E., Özen, F. B., Oral, Z. C., & Çelmeli, F. (2026). KIT D816V‐Negative Smoldering Systemic Mastocytosis in an Adolescent Treated With Midostaurin. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70809
Vancouver
Külice GK, Aydın S, Tekmenuray-Ünal A, Öz A, Onkun E, Özen FB, et al. KIT D816V‐Negative Smoldering Systemic Mastocytosis in an Adolescent Treated With Midostaurin. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70809
BibTeX
@article{Klice2026,
author = {Külice, Güney Küçük and Aydın, Sultan and Tekmenuray-Ünal, Aysel and Öz, Ayşe and Onkun, Enes and Özen, Fatma Betül and Oral, Zeycan Canıtez and Çelmeli, Fatih},
title = {KIT D816V‐Negative Smoldering Systemic Mastocytosis in an Adolescent Treated With Midostaurin},
journal = {Pediatric Blood & Cancer},
year = {2026},
doi = {10.1002/1545-5017.70809}
}
EUVIMED